Entity Common Stock, Shares Outstanding of MERRIMACK PHARMACEUTICALS INC from 30 Apr 2012 to 15 Mar 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
MERRIMACK PHARMACEUTICALS INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Apr 2012 to 15 Mar 2024.
  • MERRIMACK PHARMACEUTICALS INC Entity Common Stock, Shares Outstanding for the quarter ending 15 Mar 2024 was 14,531,760, a 1.9% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

MERRIMACK PHARMACEUTICALS INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 14,531,760 +276,656 +1.9% 15 Mar 2024 10-K/A 21 Mar 2024 2023 FY
Q3 2023 14,320,953 +910,710 +6.8% 31 Oct 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 14,320,953 +910,710 +6.8% 01 Aug 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 14,255,104 +844,861 +6.3% 07 Mar 2023 10-K 09 Mar 2023 2022 FY
Q3 2022 13,410,243 0 0% 01 Nov 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 13,410,243 0 0% 02 Aug 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 13,410,243 0 0% 07 Mar 2022 10-K 09 Mar 2022 2021 FY
Q3 2021 13,410,243 +30,000 +0.22% 02 Nov 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 13,410,243 +30,000 +0.22% 02 Aug 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 13,410,243 +30,000 +0.22% 08 Mar 2021 10-K 10 Mar 2021 2020 FY
Q3 2020 13,380,243 +17,292 +0.13% 02 Nov 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 13,380,243 +30,422 +0.23% 03 Aug 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 13,380,243 +37,459 +0.28% 08 Mar 2020 10-K 12 Mar 2020 2019 FY
Q3 2019 13,362,951 +20,167 +0.15% 08 Nov 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 13,349,821 +7,037 +0.05% 10 Jul 2019 10-Q 17 Jul 2019 2019 Q2
Q1 2019 13,342,784 0 0% 27 Feb 2019 10-K 06 Mar 2019 2018 FY
Q3 2018 13,342,784 +9,817 +0.07% 01 Nov 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 13,342,784 -119,450,472 -90% 02 Aug 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 13,342,784 -119,085,137 -90% 07 Mar 2018 10-K 12 Mar 2018 2017 FY
Q3 2017 13,332,967 -116,282,977 -90% 07 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 132,793,256 +3,552,460 +2.7% 08 Aug 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 132,427,921 +4,702,791 +3.7% 09 May 2017 10-Q 10 May 2017 2017 Q1
Q3 2016 129,615,944 +14,041,815 +12% 04 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 129,240,796 +17,821,670 +16% 29 Jul 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 127,725,130 +17,700,792 +16% 27 Apr 2016 10-Q 02 May 2016 2016 Q1
Q3 2015 115,574,129 +9,689,991 +9.2% 31 Oct 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 111,419,126 +6,831,539 +6.5% 31 Jul 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 110,024,338 +6,619,187 +6.4% 30 Apr 2015 10-Q 07 May 2015 2015 Q1
Q4 2014 106,934,746 13 Feb 2015 10-K 27 Feb 2015 2014 FY
Q3 2014 105,884,138 +3,536,614 +3.5% 31 Oct 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 104,587,587 +2,377,958 +2.3% 31 Jul 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 103,405,151 +7,317,231 +7.6% 30 Apr 2014 10-Q 06 May 2014 2014 Q1
Q3 2013 102,347,524 +8,166,105 +8.7% 31 Oct 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 102,209,629 +8,490,635 +9.1% 31 Jul 2013 10-Q 08 Aug 2013 2013 Q2
Q1 2013 96,087,920 +2,787,959 +3% 30 Apr 2013 10-Q 13 May 2013 2013 Q1
Q3 2012 94,181,419 31 Oct 2012 10-Q 14 Nov 2012 2012 Q3
Q2 2012 93,718,994 31 Jul 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 93,299,961 30 Apr 2012 10-Q 15 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.